Current Advances of Mitochondrial Dysfunction and Cardiovascular Disease and Promising Therapeutic Strategies

被引：10
|
作者：
Xia, Dexiang [1 ]
Liu, Yue [1 ]
Wu, Peng [2 ]
Wei, Dangheng [1 ,3 ]
机构：
[1] Univ South China, Hengyang Med Sch, Hunan Int Sci & Technol Cooperat Base Arterioscler, Inst Cardiovasc Dis,Key Lab Arteriosclerol Hunan P, Hengyang, Peoples R China
[2] Hengyang Maternal & Child Hlth Hosp, Hengyang, Peoples R China
[3] Univ South China, Hengyang 421001, Hunan, Peoples R China
来源：
AMERICAN JOURNAL OF PATHOLOGY | 2023年 / 193卷 / 10期
基金：
中国国家自然科学基金;
关键词：
ELECTRON-TRANSPORT CHAIN; ISCHEMIA-REPERFUSION INJURY; DNA COPY NUMBER; OXIDATIVE STRESS; HEART-FAILURE; DOUBLE-BLIND; MYOCARDIAL-ISCHEMIA; DOWN-REGULATION; KETONE-BODIES; BIOGENESIS;
D O I：
10.1016/j.ajpath.2023.06.013
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Mitochondria are cellular power stations and essential organelles for maintaining cellular homeostasis. Dysfunctional mitochondria have emerged as a key factor in the occurrence and development of car-diovascular disease. This review focuses on advances in the relationship between mitochondrial dysfunction and cardiovascular diseases such as atherosclerosis, heart failure, myocardial ischemia reperfusion injury, and pulmonary arterial hypertension. The clinical value and challenges of mitochondria-targeted strategies, including mitochondria-targeted antioxidants, mitochondrial quality control modulators, mitochondrial function protectors, mitochondrial biogenesis promoters, and recently developed mitochondrial transplants, are also discussed. (Am J Pathol 2023,
引用
收藏
页码：1485 / 1500
页数：16
相关论文
共 50 条
  • [41] Transcription factor EB, a promising therapeutic target in cardiovascular disease
    Yan, Xin
    Yang, Li
    Fu, Xiaolei
    Luo, Xin
    Wang, Chengming
    Xie, Qiu Ping
    Ouyang, Fan
    PEERJ, 2024, 12
  • [42] Adenosine A(3) Receptor: A Promising Therapeutic Target in Cardiovascular Disease
    Nishat, Shamama
    Khan, Luqman A.
    Ansari, Zafar M.
    Basir, Seemi F.
    CURRENT CARDIOLOGY REVIEWS, 2016, 12 (01) : 18 - 26
  • [43] Roles and mechanisms of renalase in cardiovascular disease: A promising therapeutic target
    Li, Yue
    Wu, Weidong
    Liu, Weihong
    Zhou, Mingxue
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 131
  • [44] Transcription factor EB, a promising therapeutic target in cardiovascular disease
    Yan, Xin
    Yang, Li
    Fu, Xiaolei
    Luo, Xin
    Wang, Chengming
    Xie, Qiu Ping
    Ouyang, Fan
    PEERJ COMPUTER SCIENCE, 2024, 12
  • [45] Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies
    Elfawy, Hasnaa A.
    Das, Biswadeep
    LIFE SCIENCES, 2019, 218 : 165 - 184
  • [46] Advances in Cancer Research: Current and Future Diagnostic and Therapeutic Strategies
    Liu, Xiaohui
    Jiang, Hui
    Wang, Xuemei
    BIOSENSORS-BASEL, 2024, 14 (02):
  • [47] Targeted mitochondrial nanomaterials in biomedicine: Advances in therapeutic strategies and imaging modalities
    Chen, Zhihua
    Chen, Linjie
    Lyu, Tai dong
    Weng, Shoutao
    Xie, Yihao
    Jin, Yuxin
    Wu, Ouqiang
    Jones, Morgan
    Kwan, Kenny
    Makvnadi, Pooyan
    Li, Bin
    Sharopov, Farukh
    Ma, Chao
    Li, Huaqiong
    Wu, Aimin
    ACTA BIOMATERIALIA, 2024, 186 : 1 - 29
  • [48] Metformin and fibromyalgia pathophysiology: current insights and promising future therapeutic strategies
    Abotaleb, Hanin Abdulbaset
    Alghamdi, Badrah S.
    MOLECULAR BIOLOGY REPORTS, 2025, 52 (01)
  • [49] COPD: Optimal Current Treatment Strategies and Promising New Therapeutic Modalities
    Starakis, Ioannis
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2009, 5 (02) : 73 - 80
  • [50] Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease
    Lewis, Caitlin, V
    Taylor, W. Robert
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2020, 319 (06): : H1227 - H1233
12345